Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
4.980
-0.270 (-5.14%)
At close: Dec 12, 2025, 4:00 PM EST
4.930
-0.050 (-1.00%)
After-hours: Dec 12, 2025, 6:04 PM EST
AVR Market Cap
AVR has a market cap or net worth of $206 million as of December 12, 2025. Its market cap has increased by 52.45% in one year.
Market Cap
206.00M
Enterprise Value
198.87M
1-Year Change
52.45%
Ranking
Category
Stock Price
$4.98
Market Cap Chart
Since the IPO on October 23, 2017, AVR's market cap has increased from $49.67M to $206.00M, an increase of 314.73%. That is a compound annual growth rate of 19.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 206.00M | 12.00% |
| Dec 31, 2024 | 183.94M | -20.93% |
| Dec 29, 2023 | 232.62M | 10.90% |
| Dec 30, 2022 | 209.76M | 100.65% |
| Dec 31, 2021 | 104.54M | 525.78% |
| Dec 22, 2020 | 16.71M | -59.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |